Latuda Further Proves Effectiveness in Schizophrenia

Sunovion Pharmaceuticals recently released the results of a third Phase III clinical trial involving its schizophrenia drug, Latuda. Known generically as lurasidone hydrochloride, this medication was administered to volunteers diagnosed with schizophrenia in a worldwide trial. Doses of 80 mg and 160 mg were administered; only the 80 mg dose currently has FDA approval. Both dosages showed significant effectiveness compared to placebo.

Schizophrenia Treatment Center

Most Insurance Accepted.
Innovative Schizophrenia Treatment.
Call 305-493-8938 Today

In total, almost 3,000 adult participants were involved in the Phase III clinical trials for Latuda. Success was measured at six weeks according to scales that gauged degrees of positive and negative symptoms and indicators of overall patient function. Adverse effects rates were low compared to placebo, reported the pharmaceutical company.

Dosage of Latuda typically begins at 40 mg once a day and is titrated as necessary according to physician discretion. Those with symptoms of schizophrenia should seek evaluation and treatment from a mental health provider; a variety of drugs are available for schizophrenia in addition to Latuda. Drug choice for the treatment of schizophrenia is typically dependent on such factors as tolerance for the side effects, efficacy in the particular patient, cost and physician preference. Latuda and other prescription drugs should only be taken under the care of a medical practitioner.

Read more: http://www.businesswire.com/news/home/20101208006550/en/Latuda%C2%AE-lur...

Schizophrenia Treatment Center

Most Insurance Accepted.
Innovative Schizophrenia Treatment.
Call 305-493-8938 Today

More Articles

Treating schizophrenia with medication often yields positive results. Nowadays, there are many...

An estimated 30% of people with schizophrenia have refractory schizophrenia, which means their...

Understanding the pathophysiology of schizophrenia (or, in other words, the physiological...

There are a number of talented musicians who have suffered from schizophrenia at some point in...

While most people can’t fathom purposely hurting themselves, self-injury is not uncommon with certain types of psychiatric disorders. Although it...

More Articles

More Articles

Treating schizophrenia with medication often yields positive results. Nowadays, there are many...

An estimated 30% of people with schizophrenia have refractory schizophrenia, which means their...

Understanding the pathophysiology of schizophrenia (or, in other words, the physiological...

There are a number of talented musicians who have suffered from schizophrenia at some point in...

While most people can’t fathom purposely hurting themselves, self-injury is not uncommon with certain types of psychiatric disorders. Although it...

Although schizophrenia goes back several thousand years, this most serious of psychiatric disorders was not officially coined “schizophrenia”...

It is not uncommon for people with schizophrenia to exhibit abnormal movements. These may include rocking, pacing, posturing, strange mannerisms,...

There are two commonly used sets of criteria for diagnosing schizophrenia and other mental health disorders: the Diagnostic and Statistical Manual...

The neurotransmitter serotonin is known to influence a number of important brain functions, including perception, mood, sleep, appetite, cognition...

There are a number of different research methods used in psychology, but one of the most interesting to the layperson is the case study. Case...

The question of whether people with schizophrenia know they are ill is actually quite...

The term "schizophrenic break" refers to an episode of acute psychosis in someone with...

Creatine is a type of acid naturally manufactured by our liver, pancreas and kidneys. One of its primary roles in the body is to provide energy...

No one knows exactly what causes schizophrenia, and there are a number of...

Acute schizophrenia is what most people think of when they think of schizophrenia: varying...